JP MORGAN/CALL/BOSTON SCIENTIFIC/80/0.1/15.11.24 | Real-time Bid/Ask 04:05:12 2024-06-20 am EDT | ||
| 0.58 EUR / 0.62 EUR | +1.69% |
|
| Current month | +3.51% | ||
| 1 month | +3.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-06-20 | 0.58 | -1.69% |
| 24-06-19 | 0.59 | +5.36% |
| 24-06-18 | 0.56 | -15.15% |
| 24-06-17 | 0.66 | +4.76% |
| 24-06-14 | 0.63 | -4.55% |
Delayed Quote Börse Stuttgart
Last update June 20, 2024 at 03:53 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK57HK |
| ISIN | DE000JK57HK9 |
| Date issued | 2024-04-05 |
| Strike | 80 $ |
| Maturity | 2024-11-15 (149 Days) |
| Parity | 10 : 1 |
| Emission price | 0.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.69 € |
|---|---|
| Lowest since issue | 0.33 € |
| Spread | 0.04 € |
| Spread % | 6.45% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
76.31
USD
Average target price
82
USD
Spread / Average Target
+7.45%
- Stock Market
- Warrants
- Warrant
